Correlation Engine 2.0
Clear Search sequence regions


Human parthenogenetic embryonic stem cells (hpESCs) established from artificially activated oocytes have a wider immune-matching ability because of their homozygosity in the major histocompatibility complex alleles. Whether these cells possess the differentiation capacity similar to regular human embryonic stem cells (hESCs) derived from fertilized eggs is unclear. The aims of this study were to determine whether hpESCs could be differentiated into multipotent mesenchymal stem cell (MSC)-like cells in vitro and then compare these cells with those derived from hESCs. MSC-like cells were obtained from both hpESCs and hESCs, which exhibited similar cell surface marker expression profiles. Further analyses revealed that cells derived from hpESCs possessed stronger osteogenic but weaker adipogenic potentials compared with cells derived from hESCs. This is the first work that demonstrates the differentiation of hpESCs into multipotent MSC-like cells. These hpESCs could be a potential source for cell-based therapies.

Citation

Yao Chen, Ai Ai, Zheng Ya Tang, Guang Dong Zhou, Wei Liu, Yilin Cao, Wen Jie Zhang. Mesenchymal-like stem cells derived from human parthenogenetic embryonic stem cells. Stem cells and development. 2012 Jan;21(1):143-51

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 21457005

View Full Text